Table 1 RBM3 immunoexpression in different urothelial lesions
Number | Highest stain intensity (%) | Staining intensity (mean) | % of RBM3 labeling (mean) | H-score (mean) | ||||
|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | |||||
Benign urothelium | 112 | 8 (7 %) | 21 (19 %) | 24 (22 %) | 58 (52 %) | 2.2 | 61.1 | 97.3 |
Malignant urothelium | 274 | |||||||
CIS | 65 | 4 (6 %) | 12 (18 %) | 15 (23 %) | 34 (52 %) | 2.2 | 62.5 | 140.7 |
PAP | 22 | 5 (23 %) | 5 (23 %) | 4 (18 %) | 8 (36 %) | 1.7 | 37.9 | 64.0 |
Invasive | 152 | 39 (25 %) | 28 (18 %) | 34 (22 %) | 52 (34 %) | 1.6 | 40.2 | 40.2 |
Primary (matched) | 35 | 14 (40 %) | 14 (40 %) | 3 (9 %) | 4 (11 %) | 0.9 | 29.3 | 26.1 |
Metastasis (matched) | 35 | 6 (17 %) | 5 (14 %) | 6 (17 %) | 18 (51 %) | 2.0 | 50.9 | 95.6 |